Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression

<div>The expression and prognostic value of GNGT1 and NMU in NSCLC patients. (a) Genetic alteration of GNGT1 and NMU genes in NSCLC patients. (b) Illustration of the alteration frequency of GNGT1 and NMU genes in NSCLC patients. (c) Coexpression between GNGT1 and NMU. (d) Overall survival analysis for GNGT1 and NMU genes in NSCLC patients. (e) Combined diagnosis of GNGT1 and NMU genes in NSCLC patients.</div>

Disease Markers

fig5

Figure 5

Figure 5: Identified GNGT1 and NMU as Combined Diagnosis Biomarker of Non-Small-Cell Lung Cancer Utilizing Bioinformatics and Logistic Regression 